Literature DB >> 19307778

Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.

Toshio Sone1, Kazuo Dairiki, Keiko Morikubo, Kimiko Shimizu, Hajime Tsunoo, Takeshi Mori, Kohsuke Kino.   

Abstract

BACKGROUND: Pollens from species of the Cupressaceae family are one of the most important causes of respiratory allergies worldwide. Many patients with pollinosis have specific IgE to both allergens from Japanese cedar and Japanese cypress pollen. We set out to identify T cell epitopes in Cha o 2, the second major allergen of Japanese cypress pollen.
METHODS: T cell lines (TCL) and T cell clones (TCC) specific to Cha o 2 were generated from allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen. T cell epitopes in Cha o 2 were identified by responses of TCL stimulated with overlapping peptides. Abilities of IL-4/IFN-gamma production by TCC were evaluated using enzyme immunoassay.
RESULTS: Using TCL, 11 dominant and subdominant T cell epitopes were identified in Cha o 2. The subsets of TCC were predominantly of T helper 2-type. A T cell epitope p141-160 in Cha o 2 and corresponding peptide in Cry j 2 showed high homology. Although TCC PC.205.159 responded to stimulation with p141-160 in Cha o 2, it did not respond with corresponding peptide in Cry j 2, therefore, the T cell epitope was unique to Cha o 2.
CONCLUSIONS: Eleven T cell epitopes that were identified are unique to Cha o 2. Cha o 2 is a putative aeroallergen that can potentially sensitize human T cells. We concluded that generation of T cells specific to Cha o 2 in allergic patients acts as one of the causes of continuous allergic symptoms in April.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307778     DOI: 10.2332/allergolint.08-OA-0027

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  5 in total

1.  Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies.

Authors:  Fumio Takaiwa; Lijun Yang
Journal:  Transgenic Res       Date:  2014-03-18       Impact factor: 2.788

2.  Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure.

Authors:  Sho Kanzaki; Kazuhiro Hashiguchi; Ken-Ichiro Wakabayashi; Kiyochika Suematsu; Kimihiro Okubo
Journal:  J Drug Assess       Date:  2016-09-27

3.  Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Athanasia Anagnostou; David Fitz-Patrick; William Hearl; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

4.  T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.

Authors:  Shinya Takaishi; Saburo Saito; Tomonori Endo; Daiya Asaka; Yuhya Wakasa; Hidenori Takagi; Kenjiro Ozawa; Fumio Takaiwa; Nobuyoshi Otori; Hiromi Kojima
Journal:  Immunology       Date:  2019-08-23       Impact factor: 7.397

5.  Predicting HLA CD4 Immunogenicity in Human Populations.

Authors:  Sandeep Kumar Dhanda; Edita Karosiene; Lindy Edwards; Alba Grifoni; Sinu Paul; Massimo Andreatta; Daniela Weiskopf; John Sidney; Morten Nielsen; Bjoern Peters; Alessandro Sette
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.